Cover Image
Market Research Report
Product code 
1061194

Global Clinical Trials Market Insights and Forecast to 2028

Published: | QYResearch | 113 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Clinical Trials Market Insights and Forecast to 2028
Published: March 1, 2022
QYResearch
Content info: 113 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Clinical trials are research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people.

Market Analysis and Insights: Global Clinical Trials Market

The global Clinical Trials market size is projected to reach US$ 88750 million by 2028, from US$ 52330 million in 2021, at a CAGR of 7.7% during 2022-2028.

Fully considering the economic change by this health crisis, Phase I accounting for % of the Clinical Trials global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Interventional segment is altered to an % CAGR throughout this forecast period.

China Clinical Trials market size is valued at US$ million in 2021, while the North America and Europe Clinical Trials are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Clinical Trials landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trials market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trials market.

Global Clinical Trials Scope and Market Size

Clinical Trials market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Segment by Application

  • Interventional
  • Observational
  • Expanded Access

By Company

  • Quintiles IMS
  • Paraxel International Corporation
  • Charles River Laboratories
  • ICON plc
  • SGS SA
  • Pharmaceutical Product Development, LLC
  • Wuxi AppTec Inc.
  • PRA Health Sciences
  • Chiltern International Ltd.
  • INC Research

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Clinical Trials Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Phase I
    • 1.2.3 Phase II
    • 1.2.4 Phase III
    • 1.2.5 Phase IV
  • 1.3 Market by Application
    • 1.3.1 Global Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Interventional
    • 1.3.3 Observational
    • 1.3.4 Expanded Access
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Clinical Trials Market Perspective (2017-2028)
  • 2.2 Clinical Trials Growth Trends by Region
    • 2.2.1 Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Clinical Trials Historic Market Size by Region (2017-2022)
    • 2.2.3 Clinical Trials Forecasted Market Size by Region (2023-2028)
  • 2.3 Clinical Trials Market Dynamics
    • 2.3.1 Clinical Trials Industry Trends
    • 2.3.2 Clinical Trials Market Drivers
    • 2.3.3 Clinical Trials Market Challenges
    • 2.3.4 Clinical Trials Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Clinical Trials Players by Revenue
    • 3.1.1 Global Top Clinical Trials Players by Revenue (2017-2022)
    • 3.1.2 Global Clinical Trials Revenue Market Share by Players (2017-2022)
  • 3.2 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Clinical Trials Revenue
  • 3.4 Global Clinical Trials Market Concentration Ratio
    • 3.4.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2021
  • 3.5 Clinical Trials Key Players Head office and Area Served
  • 3.6 Key Players Clinical Trials Product Solution and Service
  • 3.7 Date of Enter into Clinical Trials Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Trials Breakdown Data by Type

  • 4.1 Global Clinical Trials Historic Market Size by Type (2017-2022)
  • 4.2 Global Clinical Trials Forecasted Market Size by Type (2023-2028)

5 Clinical Trials Breakdown Data by Application

  • 5.1 Global Clinical Trials Historic Market Size by Application (2017-2022)
  • 5.2 Global Clinical Trials Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Clinical Trials Market Size (2017-2028)
  • 6.2 North America Clinical Trials Market Size by Type
    • 6.2.1 North America Clinical Trials Market Size by Type (2017-2022)
    • 6.2.2 North America Clinical Trials Market Size by Type (2023-2028)
    • 6.2.3 North America Clinical Trials Market Share by Type (2017-2028)
  • 6.3 North America Clinical Trials Market Size by Application
    • 6.3.1 North America Clinical Trials Market Size by Application (2017-2022)
    • 6.3.2 North America Clinical Trials Market Size by Application (2023-2028)
    • 6.3.3 North America Clinical Trials Market Share by Application (2017-2028)
  • 6.4 North America Clinical Trials Market Size by Country
    • 6.4.1 North America Clinical Trials Market Size by Country (2017-2022)
    • 6.4.2 North America Clinical Trials Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Clinical Trials Market Size (2017-2028)
  • 7.2 Europe Clinical Trials Market Size by Type
    • 7.2.1 Europe Clinical Trials Market Size by Type (2017-2022)
    • 7.2.2 Europe Clinical Trials Market Size by Type (2023-2028)
    • 7.2.3 Europe Clinical Trials Market Share by Type (2017-2028)
  • 7.3 Europe Clinical Trials Market Size by Application
    • 7.3.1 Europe Clinical Trials Market Size by Application (2017-2022)
    • 7.3.2 Europe Clinical Trials Market Size by Application (2023-2028)
    • 7.3.3 Europe Clinical Trials Market Share by Application (2017-2028)
  • 7.4 Europe Clinical Trials Market Size by Country
    • 7.4.1 Europe Clinical Trials Market Size by Country (2017-2022)
    • 7.4.2 Europe Clinical Trials Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Clinical Trials Market Size (2017-2028)
  • 8.2 Asia-Pacific Clinical Trials Market Size by Type
    • 8.2.1 Asia-Pacific Clinical Trials Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Clinical Trials Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Clinical Trials Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Clinical Trials Market Size by Application
    • 8.3.1 Asia-Pacific Clinical Trials Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Clinical Trials Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Clinical Trials Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Clinical Trials Market Size by Region
    • 8.4.1 Asia-Pacific Clinical Trials Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Clinical Trials Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Clinical Trials Market Size (2017-2028)
  • 9.2 Latin America Clinical Trials Market Size by Type
    • 9.2.1 Latin America Clinical Trials Market Size by Type (2017-2022)
    • 9.2.2 Latin America Clinical Trials Market Size by Type (2023-2028)
    • 9.2.3 Latin America Clinical Trials Market Share by Type (2017-2028)
  • 9.3 Latin America Clinical Trials Market Size by Application
    • 9.3.1 Latin America Clinical Trials Market Size by Application (2017-2022)
    • 9.3.2 Latin America Clinical Trials Market Size by Application (2023-2028)
    • 9.3.3 Latin America Clinical Trials Market Share by Application (2017-2028)
  • 9.4 Latin America Clinical Trials Market Size by Country
    • 9.4.1 Latin America Clinical Trials Market Size by Country (2017-2022)
    • 9.4.2 Latin America Clinical Trials Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Clinical Trials Market Size (2017-2028)
  • 10.2 Middle East & Africa Clinical Trials Market Size by Type
    • 10.2.1 Middle East & Africa Clinical Trials Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Clinical Trials Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Clinical Trials Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Clinical Trials Market Size by Application
    • 10.3.1 Middle East & Africa Clinical Trials Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Clinical Trials Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Clinical Trials Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Clinical Trials Market Size by Country
    • 10.4.1 Middle East & Africa Clinical Trials Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Clinical Trials Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Quintiles IMS
    • 11.1.1 Quintiles IMS Company Details
    • 11.1.2 Quintiles IMS Business Overview
    • 11.1.3 Quintiles IMS Clinical Trials Introduction
    • 11.1.4 Quintiles IMS Revenue in Clinical Trials Business (2017-2022)
    • 11.1.5 Quintiles IMS Recent Developments
  • 11.2 Paraxel International Corporation
    • 11.2.1 Paraxel International Corporation Company Details
    • 11.2.2 Paraxel International Corporation Business Overview
    • 11.2.3 Paraxel International Corporation Clinical Trials Introduction
    • 11.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2017-2022)
    • 11.2.5 Paraxel International Corporation Recent Developments
  • 11.3 Charles River Laboratories
    • 11.3.1 Charles River Laboratories Company Details
    • 11.3.2 Charles River Laboratories Business Overview
    • 11.3.3 Charles River Laboratories Clinical Trials Introduction
    • 11.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2017-2022)
    • 11.3.5 Charles River Laboratories Recent Developments
  • 11.4 ICON plc
    • 11.4.1 ICON plc Company Details
    • 11.4.2 ICON plc Business Overview
    • 11.4.3 ICON plc Clinical Trials Introduction
    • 11.4.4 ICON plc Revenue in Clinical Trials Business (2017-2022)
    • 11.4.5 ICON plc Recent Developments
  • 11.5 SGS SA
    • 11.5.1 SGS SA Company Details
    • 11.5.2 SGS SA Business Overview
    • 11.5.3 SGS SA Clinical Trials Introduction
    • 11.5.4 SGS SA Revenue in Clinical Trials Business (2017-2022)
    • 11.5.5 SGS SA Recent Developments
  • 11.6 Pharmaceutical Product Development, LLC
    • 11.6.1 Pharmaceutical Product Development, LLC Company Details
    • 11.6.2 Pharmaceutical Product Development, LLC Business Overview
    • 11.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
    • 11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2017-2022)
    • 11.6.5 Pharmaceutical Product Development, LLC Recent Developments
  • 11.7 Wuxi AppTec Inc.
    • 11.7.1 Wuxi AppTec Inc. Company Details
    • 11.7.2 Wuxi AppTec Inc. Business Overview
    • 11.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
    • 11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2017-2022)
    • 11.7.5 Wuxi AppTec Inc. Recent Developments
  • 11.8 PRA Health Sciences
    • 11.8.1 PRA Health Sciences Company Details
    • 11.8.2 PRA Health Sciences Business Overview
    • 11.8.3 PRA Health Sciences Clinical Trials Introduction
    • 11.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2017-2022)
    • 11.8.5 PRA Health Sciences Recent Developments
  • 11.9 Chiltern International Ltd.
    • 11.9.1 Chiltern International Ltd. Company Details
    • 11.9.2 Chiltern International Ltd. Business Overview
    • 11.9.3 Chiltern International Ltd. Clinical Trials Introduction
    • 11.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2017-2022)
    • 11.9.5 Chiltern International Ltd. Recent Developments
  • 11.10 INC Research
    • 11.10.1 INC Research Company Details
    • 11.10.2 INC Research Business Overview
    • 11.10.3 INC Research Clinical Trials Introduction
    • 11.10.4 INC Research Revenue in Clinical Trials Business (2017-2022)
    • 11.10.5 INC Research Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Clinical Trials Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Phase I
  • Table 3. Key Players of Phase II
  • Table 4. Key Players of Phase III
  • Table 5. Key Players of Phase IV
  • Table 6. Global Clinical Trials Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 7. Global Clinical Trials Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 8. Global Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
  • Table 9. Global Clinical Trials Market Share by Region (2017-2022)
  • Table 10. Global Clinical Trials Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 11. Global Clinical Trials Market Share by Region (2023-2028)
  • Table 12. Clinical Trials Market Trends
  • Table 13. Clinical Trials Market Drivers
  • Table 14. Clinical Trials Market Challenges
  • Table 15. Clinical Trials Market Restraints
  • Table 16. Global Clinical Trials Revenue by Players (2017-2022) & (US$ Million)
  • Table 17. Global Clinical Trials Revenue Share by Players (2017-2022)
  • Table 18. Global Top Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2021)
  • Table 19. Ranking of Global Top Clinical Trials Companies by Revenue (US$ Million) in 2021
  • Table 20. Global 5 Largest Players Market Share by Clinical Trials Revenue (CR5 and HHI) & (2017-2022)
  • Table 21. Key Players Headquarters and Area Served
  • Table 22. Key Players Clinical Trials Product Solution and Service
  • Table 23. Date of Enter into Clinical Trials Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 26. Global Clinical Trials Revenue Market Share by Type (2017-2022)
  • Table 27. Global Clinical Trials Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 28. Global Clinical Trials Revenue Market Share by Type (2023-2028)
  • Table 29. Global Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. Global Clinical Trials Revenue Share by Application (2017-2022)
  • Table 31. Global Clinical Trials Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 32. Global Clinical Trials Revenue Share by Application (2023-2028)
  • Table 33. North America Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. North America Clinical Trials Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. North America Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. North America Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. North America Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. North America Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Europe Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Europe Clinical Trials Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Europe Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Europe Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Europe Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
  • Table 44. Europe Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Clinical Trials Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. Asia Pacific Clinical Trials Market Size by Region (2017-2022) & (US$ Million)
  • Table 50. Asia Pacific Clinical Trials Market Size by Region (2023-2028) & (US$ Million)
  • Table 51. Latin America Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Latin America Clinical Trials Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Latin America Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Latin America Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Latin America Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Latin America Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Clinical Trials Market Size by Type (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Clinical Trials Market Size by Type (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Clinical Trials Market Size by Application (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Clinical Trials Market Size by Application (2023-2028) & (US$ Million)
  • Table 61. Middle East and Africa Clinical Trials Market Size by Country (2017-2022) & (US$ Million)
  • Table 62. Middle East and Africa Clinical Trials Market Size by Country (2023-2028) & (US$ Million)
  • Table 63. Quintiles IMS Company Details
  • Table 64. Quintiles IMS Business Overview
  • Table 65. Quintiles IMS Clinical Trials Product
  • Table 66. Quintiles IMS Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 67. Quintiles IMS Recent Developments
  • Table 68. Paraxel International Corporation Company Details
  • Table 69. Paraxel International Corporation Business Overview
  • Table 70. Paraxel International Corporation Clinical Trials Product
  • Table 71. Paraxel International Corporation Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 72. Paraxel International Corporation Recent Developments
  • Table 73. Charles River Laboratories Company Details
  • Table 74. Charles River Laboratories Business Overview
  • Table 75. Charles River Laboratories Clinical Trials Product
  • Table 76. Charles River Laboratories Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 77. Charles River Laboratories Recent Developments
  • Table 78. ICON plc Company Details
  • Table 79. ICON plc Business Overview
  • Table 80. ICON plc Clinical Trials Product
  • Table 81. ICON plc Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 82. ICON plc Recent Developments
  • Table 83. SGS SA Company Details
  • Table 84. SGS SA Business Overview
  • Table 85. SGS SA Clinical Trials Product
  • Table 86. SGS SA Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 87. SGS SA Recent Developments
  • Table 88. Pharmaceutical Product Development, LLC Company Details
  • Table 89. Pharmaceutical Product Development, LLC Business Overview
  • Table 90. Pharmaceutical Product Development, LLC Clinical Trials Product
  • Table 91. Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 92. Pharmaceutical Product Development, LLC Recent Developments
  • Table 93. Wuxi AppTec Inc. Company Details
  • Table 94. Wuxi AppTec Inc. Business Overview
  • Table 95. Wuxi AppTec Inc. Clinical Trials Product
  • Table 96. Wuxi AppTec Inc. Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 97. Wuxi AppTec Inc. Recent Developments
  • Table 98. PRA Health Sciences Company Details
  • Table 99. PRA Health Sciences Business Overview
  • Table 100. PRA Health Sciences Clinical Trials Product
  • Table 101. PRA Health Sciences Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 102. PRA Health Sciences Recent Developments
  • Table 103. Chiltern International Ltd. Company Details
  • Table 104. Chiltern International Ltd. Business Overview
  • Table 105. Chiltern International Ltd. Clinical Trials Product
  • Table 106. Chiltern International Ltd. Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 107. Chiltern International Ltd. Recent Developments
  • Table 108. INC Research Company Details
  • Table 109. INC Research Business Overview
  • Table 110. INC Research Clinical Trials Product
  • Table 111. INC Research Revenue in Clinical Trials Business (2017-2022) & (US$ Million)
  • Table 112. INC Research Recent Developments
  • Table 113. Research Programs/Design for This Report
  • Table 114. Key Data Information from Secondary Sources
  • Table 115. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Clinical Trials Market Share by Type: 2021 VS 2028
  • Figure 2. Phase I Features
  • Figure 3. Phase II Features
  • Figure 4. Phase III Features
  • Figure 5. Phase IV Features
  • Figure 6. Global Clinical Trials Market Share by Application: 2021 VS 2028
  • Figure 7. Interventional Case Studies
  • Figure 8. Observational Case Studies
  • Figure 9. Expanded Access Case Studies
  • Figure 10. Clinical Trials Report Years Considered
  • Figure 11. Global Clinical Trials Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Clinical Trials Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Clinical Trials Market Share by Region: 2021 VS 2028
  • Figure 14. Global Clinical Trials Market Share by Players in 2021
  • Figure 15. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Clinical Trials Revenue in 2021
  • Figure 17. North America Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Clinical Trials Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Clinical Trials Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Clinical Trials Market Size Share by Country (2017-2028)
  • Figure 21. United States Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Clinical Trials Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Clinical Trials Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Clinical Trials Market Size Share by Country (2017-2028)
  • Figure 27. Germany Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Clinical Trials Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Clinical Trials Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Clinical Trials Market Size Share by Region (2017-2028)
  • Figure 37. China Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Latin America Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Clinical Trials Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Clinical Trials Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Clinical Trials Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Clinical Trials Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Clinical Trials Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Clinical Trials Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Clinical Trials Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Clinical Trials Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Quintiles IMS Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 57. Paraxel International Corporation Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 58. Charles River Laboratories Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 59. ICON plc Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 60. SGS SA Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 61. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 62. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 63. PRA Health Sciences Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 64. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 65. INC Research Revenue Growth Rate in Clinical Trials Business (2017-2022)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed